The short version of PPARδ fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-14 and is reviewed periodically as new material appears.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Common internet and media name. |
| Research code | GW501516 | Also written GW-1516. |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator. |
| Development status | Discontinued | Clinical development halted after rodent cancer findings. |
| Regulatory status | Prohibited in sport | Listed by WADA; not approved as medicine. |
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Baldwin's famous speech led many to believe the only way to prevent the bombing of British cities was to make a strategic bomber force so large it could, as Baldwin put it, "kill more women and children more quickly than the enemy." Even the highest levels of the RAF came to agree with this policy, publicly stating that their tests suggested that "'The best form of defence is attack' may be all-too-familiar platitudes, but they illustrate the only sound method of defending this country from air invasion. It is attack that counts." As it became clear the Germans were rapidly rearming the Luftwaffe, the fear grew RAF could not meet the objective of winning such a tit-for-tat exchange and many suggested they invest in a massive bomber building exercise. Others felt advances in fighters meant the bomber was increasingly vulnerable and suggested at least exploring a defensive approach. Among the latter group was Lindemann, test pilot and scientist, who noted in The Times in August 1934 that "To adopt a defeatist attitude in the face of such a threat is inexcusable until it has definitely been shown that all the resources of science and invention have been exhausted."
==== Corneal Allogenic Intrastromal Ring Segments (CAIRS) ==== Corneal Allogenic Intrastromal Ring Segments Keratoplasty (CAIRS Keratoplasty) represent an innovative surgical approach for the management of keratoconus, utilizing donor corneal tissue as biocompatible implants to reshape the ectatic cornea and improve visual acuity. CAIRS is a corneal transplant and due to its success rate, efficacy, safety profile and use of biologic tissue, it been recognised as such by funding bodies in Australia, the United Kingdom, Brazil, Japan, the Netherlands, Germany and numerous other countries. Unlike traditional synthetic intrastromal corneal ring segments (ICRS), which are typically made from polymethyl methacrylate (PMMA), CAIRS keratoplasty employs preserved allogeneic donor cornea to minimize risks such as extrusion, infection, or foreign body reactions associated with non-biological materials. The technique was developed by Soosan Jacob, who first described CAIRS in 2018 in a prospective interventional case series published in the Journal of Refractive Surgery. In this study, 24 eyes of 20 patients with keratoconus (grades 2–4) underwent CAIRS implantation combined with accelerated corneal collagen cross-linking (CXL). The procedure involved femtosecond laser-assisted creation of intrastromal tunnels followed by insertion of custom-cut allogeneic segments. Key outcomes included significant improvements in uncorrected distance visual acuity (UDVA) of 2.79 ± 2.65 lines and corrected distance visual acuity (CDVA) of 1.29 ± 1.33.
==== MeSH D08.244.286 – cytochrome c group ==== MeSH D08.244.286.100 – cytochromes c MeSH D08.244.286.150 – cytochromes c' MeSH D08.244.286.200 – cytochromes c1 MeSH D08.244.286.300 – cytochromes c2 MeSH D08.244.286.600 – cytochromes c6
== Reception == The film received a mixed critical reaction. Rotten Tomatoes gives it a score of 48% based on 21 reviews, with an average rating of 4.89/10. Jeanette Catsoulis of The New York Times praised Chastain's performance, noting that she "digs deep. Surrendering to her character’s smoky voice-over and disastrous judgment, the actress finds pockets of soul in a role that’s part Jessica Rabbit, part Marilyn Monroe." Rex Reed of The New York Observer rated the film three out of four stars. Reed praised the casting; "This movie boasts a terrific cast, and Ms. Chastain not only holds her own corner of every scene, she's the only thing you want to watch."
S. mutilans, like other centipedes, is a predator that kills by injecting venom into its prey. Venom is injected to immobilize and break down internal tissues. Venoms of Scolopendridae, including Scolopendra mutilans, contain neurotoxins, which are suspected to be a significant fast-acting component in venoms of many centipedes. This species mainly feeds on live animals; plant materials are occasionally consumed but its consumption is considered negligible. To get hold of the prey, this centipede grabs prey with its anterior legs, and typically envenomates prey by stabbing it using its forcipules. Little quantitative ecological and behavioural work was done for centipedes. Some studies, however, have found that centipedes are highly selective and tend to strike at the head or thorax instead of the abdomen. If the bite was made on the abdomen, the centipede would usually reposition the prey and strike again on the head or thorax. Venom availability has a significant effect on predatory response. Returning to their normal attack rate after venom extraction takes more time when facing larger prey. Research on these behaviours has suggested that the reason for centipedes to reposition their prey is to enhance the speed where neurotoxins in the venom arrive at the thoracic ganglia, where it controls limb movement or the brain. This explanation was based on the position of such ganglia locating on the abdominal side (i.e.
Sources: en.wikipedia.org
== Episode 6: Deja Vu == Matt Lee is a 20-year-old college student who suffers from fainting spells that only occur when he has a sense of Deja Vu, these fainting spells at times can cause his heart to stop all together. Matt states that when he was around 19, one day he just started feeling very light headed and had a sense of Deja Vu then shortly after he blacked out. When he woke back up and realized he had blacked out, he immediately went to the hospital, the next time he fainted had flatlined. Specifically his symptoms include a sense of tingling in his head that is followed by light-headedness, nausea, heart palpitations, loss of control, and then finally the Deja Vu before he faints. Matt is extremely afraid that these random fainting episodes could happen at any time during the day and he might not have someone to help him out, because of these he stays at home as much as he could. He expresses his disappointment in not being able to follow his goals in wanting to study computer science and wanting to find a cure or treatment that would allow him to be “free” again. Matt was admitted into Johns Hopkins Hospital for in depth testing of all his symptoms, the only definitive diagnosis known is the fact that Matt is experiencing Syncope. Syncope are essentially fainting spells that are caused by a decrease of blood reaching the brain, the only question is what is causing the decreased blood flow along with the other symptoms.
Carroll, J. T. (1975). Ireland in the War Years 1939–1945. David and Charles. ISBN 9780844805658. Coogan, Tim Pat (1993). De Valera: Long Fellow, Long Shadow. London: Hutchinson. ISBN 9780091750305. published as Eamon de Valera: The Man Who Was Ireland (New York, 1993) Coogan, Tim Pat (1990). Michael Collins. Hutchinson. ISBN 0-09-174106-8. Corcoran, Donal. "Public policy in an emerging state: The Irish Free State 1922-25." Irish Journal of Public Policy 1.1 (2009). online Dwyer, T. Ryle (2006). Big Fellow, Long Fellow: A Joint Biography of Collins and De Valera. Gill Books. ISBN 0717140849. excerpt and text search Dwyer, T. Ryle (1982). De Valera's Finest Hour 1932–59. Fanning, Ronan. Éamon de Valera: A Will to Power (2016) Foster, R. F. Modern Ireland, 1600-1972 (1989) online Girvin, Brian. "Beyond Revisionism? Some Recent Contributions to the Study of Modern Ireland." The English Historical Review 124#506, 2009, pp. 94–107. online Gwynn, Denis. The Irish Free State, 1922-1927 (Macmillan 1928); detailed coverage.online Keown, Gerard. First of the Small Nations: The Beginnings of Irish Foreign Policy in the Inter-war Years, 1919-1932 (Oxford University Press, 2016). online Kissane, Bill. "Eamon De Valera and the Survival of Democracy in Inter-War Ireland". Journal of Contemporary History (2007). 42 (2): 213–226. online Lee, J. J. Ireland, 1912-1985: politics and society (Cambridge University Press, 1989) online. McCardle, Dorothy (January 1999). The Irish Republic. Wolfhound Press. ISBN 0-86327-712-8. O'Halpin, Eunan.
For type II and inverse type II dots, either the conduction or valence band of the core is located within the bandgap of the shell, which can lead to spatial separation of charge carriers in the core and shell. For all of these core/shell systems, the deposition of the outer layer can lead to potential lattice mismatch, which can limit the ability to grow a thick shell without reducing photoluminescent performance. One such reason for the decrease in performance can be attributed to the physical strain being put on the lattice. In a case where ZnSe/ZnS (type I) and ZnSe/CdS (type II) quantum dots were being compared, the diameter of the uncoated ZnSe core (obtained using TEM) was compared to the capped core diameter (calculated via effective mass approximation model) [lattice strain source] to better understand the effect of core-shell strain. Type I heterostructures were found to induce compressive strain and "squeeze" the core, while the type II heterostructures had the effect of stretching the core under tensile strain. Because the fluorescent properties of quantum dots are dictated by nanocrystal size, induced changes in core dimensions can lead to shifting of emission wavelength, further proving why an intermediate semiconductor layer is necessary to rectify lattice mismatch and improve quantum yield. One such core/double-shell system is the CdSe/ZnSe/ZnS nanocrystal. In a study comparing CdSe/ZnS and CdSe/ZnSe nanocrystals, the former was found to have PL yield 84% of the latter's, due to a lattice mismatch.
=== Neuroprotection === Ciclosporin is in a phase II/III (adaptive) clinical study in Europe to determine its ability to ameliorate neuronal cellular damage and reperfusion injury (phase III) in traumatic brain injury. This multi-center study is being organized by NeuroVive Pharma and the European Brain Injury Consortium using NeuroVive's formulation of ciclosporin called Neurostat (also known by its cardioprotection brand name of Ciclomulsion). This formulation uses a lipid emulsion base instead of cremophor and ethanol. NeuroSTAT was compared to Sandimmune in a phase I study and found to be bioequivalent. In this study, NeuroSTAT did not exhibit the anaphylactic and hypersensitivity reactions found in cremophor- and ethanol-based products. Ciclosporin has been investigated as a possible neuroprotective agent in conditions such as traumatic brain injury, and has been shown in animal experiments to reduce brain damage associated with injury. Ciclosporin blocks the formation of the mitochondrial permeability transition pore, which has been found to cause much of the damage associated with head injury and neurodegenerative diseases. Ciclosporin's neuroprotective properties were first discovered in the early 1990s when two researchers (Eskil Elmér and Hiroyuki Uchino) were conducting experiments in cell transplantation. An unintended finding was that cyclosporin A was strongly neuroprotective when it crossed the blood–brain barrier. This same process of mitochondrial destruction through the opening of the MPT pore is implicated in making traumatic brain injuries much worse.
Sources: en.wikipedia.org
Global reductions in gray matter volume, thinning of the parietal and orbitofrontal cortices, and decreased hippocampal activity have been observed in long term users. The effects established so far for recreational use of ecstasy lie in the range of moderate to severe effects for serotonin transporter reduction. Impairments in multiple aspects of cognition, including attention, learning, memory, visual processing, and sleep, have been found in regular MDMA users. The magnitude of these impairments is correlated with lifetime MDMA usage and are partially reversible with abstinence. Several forms of memory are impaired by chronic ecstasy use; however, the effects for memory impairments in ecstasy users are generally small overall. MDMA use is also associated with increased impulsivity and depression. Serotonin depletion following MDMA use can cause depression in subsequent days. In some cases, depressive symptoms persist for longer periods. Some studies indicate repeated recreational use of ecstasy is associated with depression and anxiety, even after quitting the drug. Depression is one of the main reasons for cessation of use. At high doses, MDMA induces a response in the neuroimmune system that, through several mechanisms, increases the permeability of the blood–brain barrier, thereby making the brain more susceptible to environmental toxins and pathogens. In addition, MDMA has immunosuppressive effects in the peripheral nervous system and pro-inflammatory effects in the central nervous system.
The peptides are generated mainly in the cytosol by the proteasome. The proteasome is a macromolecule that consists of 28 subunits, of which half affect proteolytic activity. The proteasome degrades intracellular proteins into small peptides that are then released into the cytosol. Proteasomes can also ligate distinct peptide fragments (termed spliced peptides), producing sequences that are noncontiguous and therefore not linearly templated in the genome. The origin of spliced peptide segments can be from the same protein (cis-splicing) or different proteins (trans-splicing). The peptides have to be translocated from the cytosol into the endoplasmic reticulum (ER) to meet the MHC class I molecule, whose peptide-binding site is in the lumen of the ER. They have membrane proximal Ig fold.
Falx cerebri, that separates the left and right hemispheres of the cerebrum. It contains the superior sagittal sinus and inferior sagittal sinus. Tentorium cerebelli, which separates the cerebrum from cerebellum and contains the transverse sinus, straight sinus and superior petrosal sinus. Diaphragma sellae, that encloses the hypophyseal fossa from the superior side, cushioning the pituitary gland. It contains the anterior and posterior intercavernous sinuses. Falx cerebelli, which separates the left and right cerebellar hemispheres and contains the occipital sinus. In pathological conditions fluid such as blood can fill this space. For example a torn meningeal artery (often the middle meningeal artery) or dural venous sinus (rarely) may bleed into this potential space and result in an epidural hematoma.
Sources: en.wikipedia.org
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.
Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.
No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.